Zobrazeno 1 - 10
of 467
pro vyhledávání: '"I Bodrogi"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Cancer Chemotherapy and Pharmacology. 62:173-180
The purpose of this phase I study was to evaluate the maximum-tolerated dose (MTD), dose-limiting toxicity (DLT), the recommended dose for phase II study, pharmacokinetics, and antitumor activity of TZT-1,027 (soblidotin) in patients with non-small c
Publikováno v:
International Urology and Nephrology. 31:451-456
We evaluated the prophylactic efficacy of instillations of intravesical mitomycin C in 57 patients with primary superficial bladder cancer in a multicenter clinical trial. After complete transurethral resection of Ta–T1 G1–G2 transitional cell bl
Autor:
H. Ludwig, D. Campos, A. Bonaventura, P. Friederich, N O O'Higgins, F. Buzzi, P. Reichardt, M. Lassus, G. Romieu, H. Lurie, H. A. Chaudri, I. Bodrogi, M. Gershanovich, M. Jeffrey
Publikováno v:
Annals of Oncology. 9:639-645
Summary Background The study compares letrozole and aminoglutethimide (AG), a standard therapy for postmenopausal women with advanced breast cancer, previously treated with antioestrogens. Patients and methods 555 women were randomly assigned letrozo
Publikováno v:
International Urology and Nephrology. 29:449-455
Authors investigated PSA concentration and preoperative prostate volume in 113 histologically proved BPH and 31 prostatic cancer patients. PSA concentration was measured with the Hybritech kit, the prostate volume by ultrasound with the help of an el
Publikováno v:
Medical and Pediatric Oncology. 22:33-38
One hundred fifty children of 113 fathers with testicular tumour treated from 1979 on the National Institute of Oncology, Budapest, were studied. Three groups were formed on the basis of the time of conception; 69 children were born before the illnes
Publikováno v:
International journal of oncology. 9(5)
The molecular genetics of testicular germ cell tumours (TGCT) are still largely unknown. We investigated 20 TGCT tumours for allelic losses (LOH) of tumour supressor genes BRCA1, TP53 and of THRA1 on chromosome 17. We observed an overall loss of 50%
Publikováno v:
Oncology. 49:376-380
Chromosome aberrations were studied in peripheral blood lymphocytes from untreated testicular cancer patients and others treated with chemo- and/or radiotherapy. A distinct increase in spontaneous aberrations over the level of healthy controls was fo
Publikováno v:
Magyar onkologia. 45(5)
PURPOSE: To study the clinical characteristics of bilateral testicular tumors in the cisplatin era. PATIENTS AND METHODS: Between November 1988 and November 1998 2386 testicular cancer patients were treated in our Department and 72 bilateral germ cel
Publikováno v:
Anticancer research. 20(5C)
The expression of a multidrug resistance associated protein (MRP) has been investigated in a variety of human tumors. However, there is a lack of data regarding its expression in germ cell testicular tumors (GCTTs).MRP expression was examined by immu